Renaming Gleason Score 6 Prostate to Noncancer: A Flawed Idea Scientifically and for Patient Care
Author:
Affiliation:
1. Departments of Pathology, Urology and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD
2. Division of Urology, Brigham and Women's Hospital and Dana-Farber/Brigham and Women's Cancer Center, Boston, MA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00926
Reference29 articles.
1. Phase I dose-escalation study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors.
2. Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?
3. Gleason 6 Prostate Tumors Diagnosed in the PSA Era Do Not Demonstrate the Capacity for Metastatic Spread at the Time of Radical Prostatectomy
4. Disease-specific death and metastasis do not occur in patients with Gleason score ≤6 at radical prostatectomy
5. Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?;European Urology;2024-09
2. Patients ask and pathologists answer: ten questions around prostate cancer grading;Virchows Archiv;2024-08-17
3. Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study;European Urology Open Science;2024-08
4. Re: Hein V. Stroomberg, Signe Benzon Larsen, Torben Kjær Nielsen, J. Thomas Helgstrand, Klaus Brasso, Andreas Røder. Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.005;European Urology Oncology;2024-06
5. Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer;Asian Journal of Andrology;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3